Φιλτράρισμα ανά Last updated date SelectΜετάΠρινFrom - To Date Ημερομηνία λήξης This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Αποτελέσματα (3839) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank European Medicines Agency: Committee for Medicinal Products for Human Use 11-14 December 2005 15 Δεκέμβριος 2005Press releaseHumanMedicines European Medicines Agency recommends no changes for Tamiflu safety information 15 Δεκέμβριος 2005Press releaseHumanMedicines Committee for Orphan Medicinal Products: December 2005 meeting 9 Δεκέμβριος 2005Press releaseHumanRare diseases European Medicines Agency: Committee for Medicinal Products for Human Use 14-17 November 2005 17 Νοέμβριος 2005Press releaseHumanMedicines European Medicines Agency gives first positive opinions on medicinal products for use outside the European Union 17 Νοέμβριος 2005Press releaseMedicines European Medicines Agency update on the safety of Tamiflu 17 Νοέμβριος 2005Press releaseCorporateMedicines Committee for Orphan Medicinal Products: November 2005 meeting 11 Νοέμβριος 2005Press releaseHumanRare diseases European Union (European Commission and European Medicines Agency) and Food and Drug Administration extend confidentiality arrangements for five more years 9 Νοέμβριος 2005NewsMedicines European Medicines Agency conference on Environmental Risk Assessment for Human and Veterinary Medicinal Products 28 Οκτώβριος 2005Press releaseHumanVeterinaryMedicines European Commission legalisation of EMEA certificates to end 28 Οκτώβριος 2005Press release 1 … 335 336 337 338 339 Page 339 of 384 340 341 342 343 … 384
European Medicines Agency: Committee for Medicinal Products for Human Use 11-14 December 2005 15 Δεκέμβριος 2005Press releaseHumanMedicines
European Medicines Agency recommends no changes for Tamiflu safety information 15 Δεκέμβριος 2005Press releaseHumanMedicines
Committee for Orphan Medicinal Products: December 2005 meeting 9 Δεκέμβριος 2005Press releaseHumanRare diseases
European Medicines Agency: Committee for Medicinal Products for Human Use 14-17 November 2005 17 Νοέμβριος 2005Press releaseHumanMedicines
European Medicines Agency gives first positive opinions on medicinal products for use outside the European Union 17 Νοέμβριος 2005Press releaseMedicines
European Medicines Agency update on the safety of Tamiflu 17 Νοέμβριος 2005Press releaseCorporateMedicines
Committee for Orphan Medicinal Products: November 2005 meeting 11 Νοέμβριος 2005Press releaseHumanRare diseases
European Union (European Commission and European Medicines Agency) and Food and Drug Administration extend confidentiality arrangements for five more years 9 Νοέμβριος 2005NewsMedicines
European Medicines Agency conference on Environmental Risk Assessment for Human and Veterinary Medicinal Products 28 Οκτώβριος 2005Press releaseHumanVeterinaryMedicines